Quantcast

Latest Unigene Laboratories Stories

2011-03-24 06:30:00

PHILADELPHIA, March 24, 2011 /PRNewswire/ -- Tarsa Therapeutics today announced that the Phase III ORACAL trial of its oral recombinant salmon calcitonin in the treatment of postmenopausal osteoporosis was successfully concluded and yielded statistically significant, positive top-line results. The results will be used to support a New Drug Application (NDA) submission to the Food and Drug Administration (FDA) targeted for the fourth quarter of 2011, based on the study design and specific...

2010-11-08 08:00:00

BOONTON, N.J., Nov. 8, 2010 /PRNewswire-FirstCall/ -- Unigene Laboratories, Inc. (OTC Bulletin Board: UGNE) announces the following Webcast: What: Third Quarter 2010 Earnings Conference Call When: November 10, 2010 @ 9:00 AM Eastern Where: http://www.investorcalendar.com/ClientPage.asp?ID=162214 How: Live over the Internet -- Simply log on to the web at the address above. Contact: Lynn Rogalny, 973-265-1100, lrogalny@unigene.com If you are unable to participate during the live...

2010-09-24 08:30:00

PHILADELPHIA, BOONTON, N.J. and BRUSSELS, Sept. 24 /PRNewswire/ -- Tarsa Therapeutics, Inc. and Unigene Laboratories, Inc. (OTC Bulletin Board: UGNE) today reported preclinical data showing that calcitonin may have synergistic effects in combination with other drugs in reducing the collagen degradation associated with osteoarthritis. The data are being presented at the 2010 Osteoarthritis Research Society International (OARSI) World Congress in Brussels, Belgium. Unigene produces...

2010-08-06 08:00:00

BOONTON, N.J., August 6 /PRNewswire/ -- Unigene Laboratories, Inc. (UGNE) announces the following Webcast: What: Second Quarter 2010 Earnings Conference Call When: August 10, 2010 @ 9:00 AM Eastern Where:http://www.investorcalendar.com/ClientPage.asp?ID=160564 How: Live over the Internet --Simply log on to the web at the address above. Contact: Lynn Rogalny, 973-265-1100, lrogalny@unigene.com If you are unable to participate during the live...

2008-11-13 06:00:08

Patients who start and eventually stop regimens of a common class of osteoporosis drugs called bisphosphonates may be unable to benefit from parathyroid hormone (PTH), which can rebuild bone mass lost due to advanced stage osteoporosis. PTH has been proven to increase the volume and strength of the honeycomb-like bone infrastructure, the inner mesh that begins to diminish in old age. Bisphosphonates, the active ingredient in widely prescribed osteoporosis medications such as Fosamax,...


Word of the Day
endocarp
  • The hard inner (usually woody) layer of the pericarp of some fruits (as peaches or plums or cherries or olives) that contains the seed.
This word comes from the Greek 'endon,' in, within, plus the Greek 'kardia,' heart.
Related